Cancer cells with p53 mutations or suppressed p53 transcription have the ability to avoid p53-mediated apoptosis pathways under hypoxic conditions, leading to the selection of cancer cell clones and the production of apoptosis-resistant cells [199]. Here, TP53 is linked to cancer.